These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Major Update 2: Remdesivir for Adults With COVID-19. Kaka AS; Wilt TJ Ann Intern Med; 2022 Aug; 175(8):W81-W82. PubMed ID: 35969873 [No Abstract] [Full Text] [Related]
4. Safety profile of the antiviral drug remdesivir: An update. Fan Q; Zhang B; Ma J; Zhang S Biomed Pharmacother; 2020 Oct; 130():110532. PubMed ID: 32707440 [No Abstract] [Full Text] [Related]
5. Update Alert 2: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2). Qaseem A; Yost J; Etxeandia-Ikobaltzeta I; Abraham GM; Jokela JA; Miller MC; Forciea MA; Humphrey LL; Ann Intern Med; 2021 Dec; 174(12):W116-W117. PubMed ID: 34606308 [No Abstract] [Full Text] [Related]
6. A Potential Antiviral Treatment for COVID-19: Remdesivir. O'Malley PA Clin Nurse Spec; 2020; 34(6):257-260. PubMed ID: 33009111 [No Abstract] [Full Text] [Related]
7. Remdesivir in The Treatment of COVID-19. Rosenberg K Am J Nurs; 2021 Jan; 121(1):55. PubMed ID: 33350698 [TBL] [Abstract][Full Text] [Related]
8. COVID-19 updates: Remdesivir (Veklury) in high-risk outpatients with COVID-19. Med Lett Drugs Ther; 2022 Feb; 64(1644):31-32. PubMed ID: 35171898 [No Abstract] [Full Text] [Related]
9. Remdesivir for the treatment of COVID-19 in pregnancy. Lampejo T J Med Virol; 2021 Jul; 93(7):4114-4119. PubMed ID: 33788273 [No Abstract] [Full Text] [Related]
10. Early remdesivir treatment in COVID-19: Why wait another day? Cubeddu LX; Cubeddu RJ J Med Virol; 2021 Jul; 93(7):4078-4080. PubMed ID: 33511655 [No Abstract] [Full Text] [Related]
11. Remdesivir: a pendulum in a pandemic. Schwartz IS; Heil EL; McCreary EK BMJ; 2020 Nov; 371():m4560. PubMed ID: 33234523 [No Abstract] [Full Text] [Related]
12. Remdesivir for patients with COVID-19. Wu PE; Morris AM CMAJ; 2021 Jan; 193(4):E125. PubMed ID: 33408097 [No Abstract] [Full Text] [Related]
13. Remdesivir for COVID-19 in Europe: will it provide value for money? Dal-Ré R; Banzi R; Georgin-Lavialle S; Porcher R; Sofat R; Zeitlinger M; Rosendaal FR Lancet Respir Med; 2021 Feb; 9(2):127-128. PubMed ID: 33341157 [No Abstract] [Full Text] [Related]
14. Remdesivir (Veklury) for the Treatment of COVID-19 in Hospitalized Patients. Odeti S; Yellepeddi VK Am Fam Physician; 2021 Sep; 104(3):311-312. PubMed ID: 34523893 [No Abstract] [Full Text] [Related]
15. Assessing the evidence on remdesivir. Trøseid M; Hites M; Barratt-Due A; Ader F; Yazdanpanah Y Lancet Infect Dis; 2021 Dec; 21(12):1630-1631. PubMed ID: 34838222 [No Abstract] [Full Text] [Related]
16. Remdesivir for the Treatment of COVID-19. Allen R; Turner M; deSouza IS Am Fam Physician; 2022 Feb; 105(2):131-132. PubMed ID: 35166509 [No Abstract] [Full Text] [Related]
17. Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2). Qaseem A; Yost J; Etxeandia-Ikobaltzeta I; Abraham GM; Jokela JA; Forciea MA; Miller MC; Humphrey LL; ; Centor RM; Andrews R; Haeme R Ann Intern Med; 2021 May; 174(5):673-679. PubMed ID: 33560862 [TBL] [Abstract][Full Text] [Related]